Optimizing Partner Treatment Strategies A Centers for Disease Control and Prevention funded study to determine the best method of treating partners of patients with sexually transmitted infections Investigators
Patty Kissinger, Ph.D. – Principal Investigator
Tom Farley, M.D., MPH – Co-Principal Investigator
David H. Martin, M.D. – Co-Investigator
Jami Leichliter, Ph.D. – Co-Investigator
C. Evan Secor, Ph.D. - Co-Investigator Funding Agent
Centers for Disease Control and Prevention Participating Institutes
Delgado Sexually Transmitted
01 Women’s Health Clinic
Tulane University
Louisiana State University Description
Only about 20%-40% of partners of persons with STIs ever get treated. The result is that the index patient becomes reinfected. This is a study comprised of two randomized trials to examine partner treatment methods for men with urethritis (at Delgado STD clinic) (N=900) and women with Trichomonas vaginalis (at 01 Women’s Health Clinic) (N=360). For each study there are three arms: patient referral (the standard of care), booklet referral, and patient-delivered partner treatment. Patients with these STIs are enrolled at baseline, interviewed, (using computer-assisted, self-administered interviews) randomized and then followed at one-month for STI retesting and re-interviewing. The goal of the study is to determine which type of partner treatment is most efficacious (for getting partner treated and for preventing recurrence) and most cost effective. This study draws from our previous experience with the CDC Infertility Prevention Program, where we examined partner treatment among women infected with Chlamydia trachomatis. | 
